|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0003873,
umls-concept:C0005522,
umls-concept:C0022341,
umls-concept:C0030705,
umls-concept:C0032305,
umls-concept:C0087111,
umls-concept:C0205210,
umls-concept:C0205219,
umls-concept:C0206062,
umls-concept:C1096776,
umls-concept:C2348519
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2011-2-17
|
|
pubmed:abstractText |
Acute-onset diffuse interstitial lung disease (AoDILD) in patients with rheumatoid arthritis (RA) has been a serious concern, especially for those under treatment with biological agents which may affect the presentation and outcome of AoDILD, including Pneumocystis pneumonia (PCP). Therefore, we conducted a retrospective, multi-center study of AoDILD in RA patients receiving biological agents.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1349-7235
|
|
pubmed:author |
pubmed-author:DohiMakotoM,
pubmed-author:GotoHajimeH,
pubmed-author:HasegawaYoshinoriY,
pubmed-author:HashimotoShuS,
pubmed-author:HattaKazuhiroK,
pubmed-author:JohkohTakeshiT,
pubmed-author:KamedaHidetoH,
pubmed-author:KawaiShinichiS,
pubmed-author:MoriShunsukeS,
pubmed-author:SakaiFumikazuF,
pubmed-author:TakayanagiNoboruN,
pubmed-author:TakeuchiTsutomuT,
pubmed-author:TakiHirofumiH,
pubmed-author:TatedaKazuhiroK,
pubmed-author:TokudaHitoshiH,
pubmed-author:YamadaHidehiroH,
pubmed-author:YamanakaHisashiH,
pubmed-author:YoshidaYujiY
|
|
pubmed:copyrightInfo |
© 2011 The Japanese Society of Internal Medicine
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
50
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
305-13
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:21325762-Adult,
pubmed-meshheading:21325762-Aged,
pubmed-meshheading:21325762-Aged, 80 and over,
pubmed-meshheading:21325762-Antibodies, Monoclonal,
pubmed-meshheading:21325762-Antirheumatic Agents,
pubmed-meshheading:21325762-Arthritis, Rheumatoid,
pubmed-meshheading:21325762-Biological Agents,
pubmed-meshheading:21325762-Female,
pubmed-meshheading:21325762-Humans,
pubmed-meshheading:21325762-Japan,
pubmed-meshheading:21325762-Lung Diseases, Interstitial,
pubmed-meshheading:21325762-Male,
pubmed-meshheading:21325762-Middle Aged,
pubmed-meshheading:21325762-Pneumonia, Pneumocystis,
pubmed-meshheading:21325762-Retrospective Studies,
pubmed-meshheading:21325762-Tomography, X-Ray Computed,
pubmed-meshheading:21325762-Treatment Outcome
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Clinical and radiological features of acute-onset diffuse interstitial lung diseases in patients with rheumatoid arthritis receiving treatment with biological agents: importance of Pneumocystis pneumonia in Japan revealed by a multicenter study.
|
|
pubmed:affiliation |
Division of Rheumatology, Department of Internal Medicine, School of Medicine, Keio University, Japan. kamehide@z6.keio.jp
|
|
pubmed:publicationType |
Journal Article,
Multicenter Study
|
